Summary: A new smell test could help doctors identify those at risk of developing Parkinson’s disease up to 10 years before symptoms appear.
Source: Michigan State University.
A new study provides further evidence that a simple scratch-and-sniff test could predict Parkinson’s disease even earlier than previously thought.
According to Michigan State University researcher Honglei Chen, lead author and professor of epidemiology, the test could potentially identify certain people who are at an increased risk of developing the disease up to 10 years before they are actually diagnosed. Previous research has shown an association between sense of smell and disease progression of up to four to five years.
The federally funded study, now published online in Neurology, the official publication of the American Academy of Neurology, is also one of the first to follow black people.
“One of the key differences in our study was we followed older white and black participants for an average of about 10 years, much longer than any other previous study,” Chen said. “We found that there was a strong link between smell and disease risk for up to six years. After that, the link remained, but just wasn’t as strong.”
He added that the relationship between smell and Parkinson’s risk in black participants also appeared not as strong as in the white participant group.
“Previous studies have shown that black people are more likely to have a poor sense of smell than whites and yet may be less likely to develop Parkinson’s disease,” said Chen, who is part of MSU’s Global Impact Initiative, an effort to help accelerate research in key areas affecting the world such as health and energy.
“We found no statistical significance for a link between poor sense of smell and Parkinson’s disease in blacks, but that may have been due to the small sample size and more research is needed.”
The study also found that older men with a poor sense of smell were more likely to develop the disease compared to women.
The study included 1,510 white and 952 black participants with an average age of 75. The test asked people to smell 12 common odors including cinnamon, lemon, gasoline, soap and onion, and then select the correct answer from four choices.
Based on their scores, participants were divided into three groups – poor sense of smell, medium and good. Researchers then monitored participant health through clinical visits and phone interviews for more than a decade.
Overall, 42 people developed Parkinson’s during the study including 30 white people and 12 black people.
People with poor sense of smell were nearly five times more likely to develop the disease than people with a good sense of smell. Of the 764 people with a poor sense of smell, 26 people developed the disease, compared to just seven of the 835 people whose sense of smell was good and nine of the 863 people whose sense of smell was categorized as medium.
Researchers also discovered that the results stayed the same after adjusting for other factors that could affect risk including smoking, coffee intake and history of head injury.
“It’s important to note that not everyone with low scores on the smell test will develop Parkinson’s disease,” Chen said. “More research is needed before the smell test can be used as a screening tool for Parkinson’s, but we are definitely on to something and our goal now is to better characterize populations that are at higher risk for the disease and to identify other factors involved.”
Funding: The National Institute on Aging, National Institute of Nursing Research and National Institute of Environmental Health Sciences funded the study.
Source: Sarina Gleason – Michigan State University
Image Source: NeuroscienceNews.com image is credited to Michigan State University.
Original Research: Abstract for “Olfaction and incident Parkinson disease in US white and black older adults” by Honglei Chen, MD, PhD, Srishti Shrestha, PhD, Xuemei Huang, MD, PhD, Samay Jain, MD, MS, Xuguang Guo, PhD, Gregory J. Tranah, PhD, Melissa E. Garcia, MPH, Suzanne Satterfield, MD, Caroline Phillips, MS, and Tamara B. Harris, MD, PhD; For the Health ABC Study in Neurology. Published online September 6 2017 doi:10.1212/WNL.0000000000004382
Olfaction and incident Parkinson disease in US white and black older adults
Objective: To investigate olfaction in relation to incident Parkinson disease (PD) in US white and black older adults.
Methods: The study included 1,510 white (mean age 75.6 years) and 952 black (75.4 years) participants of the Health, Aging, and Body Composition study. We evaluated the olfaction of study participants with the Brief Smell Identification Test (BSIT) in 1999–2000. We retrospectively adjudicated PD cases identified through August 31, 2012, using multiple data sources. We used multivariable Cox models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: During an average of 9.8 years of follow-up, we identified a total of 42 incident PD cases, including 30 white and 12 black participants. Overall, poor sense of smell, as indicated by a lower BSIT score, was associated with higher risk of PD. Compared with the highest tertile of BSIT (t3), the HR was 1.3 (95% CI 0.5–3.6) for the second tertile (t2) and 4.8 (95% CI 2.0–11.2) for the lowest tertile (t1) (ptrend < 0.00001). Further analyses revealed significant associations for incident PD in both the first 5 years of follow-up (HRt1/[t2+t3] 4.2, 95% CI 1.7–10.8) and thereafter (HRt1/[t2+t3] 4.1, 95% CI 1.7–9.8). This association appeared to be stronger in white (HRt1/[t2+t3] 4.9, 95% CI 2.3–10.5) than in black participants (HRt1/[t2+t3] 2.5, 95% CI 0.8–8.1), and in men (HRt1/[t2+t3] 5.4, 95% CI 2.3–12.9) than in women (HRt1/[t2+t3] 2.9, 95% CI 1.1–7.8).Conclusions: Poor olfaction predicts PD in short and intermediate terms; the possibility of stronger associations among men and white participants warrants further investigation.
“Olfaction and incident Parkinson disease in US white and black older adults” by Honglei Chen, MD, PhD, Srishti Shrestha, PhD, Xuemei Huang, MD, PhD, Samay Jain, MD, MS, Xuguang Guo, PhD, Gregory J. Tranah, PhD, Melissa E. Garcia, MPH, Suzanne Satterfield, MD, Caroline Phillips, MS, and Tamara B. Harris, MD, PhD; For the Health ABC Study in Neurology. Published online September 6 2017 doi:10.1212/WNL.0000000000004382